Robert Torray - Torray Investment Partners
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 38,179 | 0.39 | Add 0.12% | <0.01 | $64.63 | $2,467,509 | SEC |
| 2025 Q4 | 38,135 | 0.39 | Add 0.04% | <0.01 | $67.30 | $2,566,485 | SEC |
| 2025 Q3 | 38,121 | 0.39 | Reduce 4.81% | 0.01 | $73.34 | $2,795,794 | SEC |
| 2025 Q2 | 40,048 | 0.30 | Reduce 27.69% | 0.15 | $52.02 | $2,083,297 | SEC |
| 2025 Q1 | 55,384 | 0.53 | Reduce 0.41% | <0.01 | $63.81 | $3,534,053 | SEC |
| 2024 Q4 | 55,611 | 0.38 | Add 0.64% | <0.01 | $47.81 | $2,658,762 | SEC |
| 2024 Q3 | 55,258 | 0.44 | Add 8.89% | 0.04 | $57.24 | $3,162,968 | SEC |
| 2024 Q2 | 50,748 | 0.40 | Add 6.67% | 0.03 | $52.36 | $2,657,165 | SEC |
| 2024 Q1 | 47,573 | 0.29 | Add 19.27% | 0.05 | $40.68 | $1,935,270 | SEC |
| 2023 Q4 | 39,886 | 0.24 | Add 53.38% | 0.08 | $36.96 | $1,474,187 | SEC |
| 2023 Q3 | 26,005 | 0.18 | Add 4.19% | <0.01 | $38.20 | $993,391 | SEC |
| 2023 Q2 | 24,959 | 0.16 | Add 0.99% | <0.01 | $36.07 | $900,271 | SEC |
| 2023 Q1 | 24,714 | 0.17 | Reduce 21.53% | 0.07 | $38.19 | $943,828 | SEC |
| 2022 Q4 | 31,495 | 0.32 | Reduce 4.31% | 0.01 | $56.90 | $1,792,066 | SEC |
| 2022 Q3 | 32,913 | 0.26 | Add 16.33% | 0.04 | $39.53 | $1,301,000 | SEC |
| 2022 Q2 | 28,293 | 0.24 | Reduce 25.19% | 0.06 | $44.00 | $1,245,000 | SEC |
| 2022 Q1 | 37,820 | 0.24 | Add 5.50% | 0.01 | $39.87 | $1,508,000 | SEC |
| 2021 Q4 | 35,850 | 0.21 | Reduce 23.18% | 0.07 | $40.22 | $1,442,000 | SEC |
| 2021 Q3 | 46,669 | 0.29 | Add 1.27% | <0.01 | $40.67 | $1,898,000 | SEC |
| 2021 Q2 | 46,086 | 0.31 | Reduce 1.05% | <0.01 | $45.42 | $2,093,000 | SEC |
| 2021 Q1 | 46,574 | 0.30 | Reduce 1.38% | <0.01 | $41.70 | $1,942,000 | SEC |
| 2020 Q4 | 47,226 | 0.33 | Add 1.02% | <0.01 | $42.71 | $2,017,000 | SEC |
| 2020 Q3 | 46,750 | 0.23 | Reduce 0.69% | <0.01 | $26.29 | $1,229,000 | SEC |
| 2020 Q2 | 47,074 | 0.24 | Reduce 9.60% | 0.02 | $26.81 | $1,262,000 | SEC |
| 2020 Q1 | 52,073 | 0.21 | Add 0.46% | <0.01 | $17.99 | $937,000 | SEC |
| 2019 Q4 | 51,832 | 0.16 | Add 11.82% | 0.02 | $17.73 | $919,000 | SEC |
| 2019 Q3 | 46,353 | 0.08 | Add 0.24% | <0.01 | $15.51 | $719,000 | SEC |
| 2019 Q2 | 46,243 | 0.08 | Reduce 10.77% | <0.01 | $17.17 | $794,000 | SEC |
| 2019 Q1 | 51,827 | 0.09 | $16.09 | $834,000 | SEC | ||
| 2018 Q4 | 51,827 | 0.09 | Add 18.12% | 0.01 | $14.63 | $758,000 | SEC |
| 2018 Q3 | 43,876 | 0.08 | Add 16.84% | 0.01 | $18.16 | $797,000 | SEC |
| 2018 Q2 | 37,552 | 0.07 | Reduce 3.81% | <0.01 | $16.88 | $634,000 | SEC |
| 2018 Q1 | 39,040 | 0.08 | Add 1.17% | <0.01 | $19.60 | $765,000 | SEC |
| 2017 Q4 | 38,588 | 0.08 | Add 28.86% | 0.02 | $20.27 | $782,000 | SEC |
| 2017 Q3 | 29,945 | 0.05 | Add 0.87% | <0.01 | $17.37 | $520,000 | SEC |
| 2017 Q2 | 29,687 | 0.04 | Reduce 3.57% | <0.01 | $12.83 | $381,000 | SEC |
| 2017 Q1 | 30,786 | 0.04 | Reduce 48.79% | 0.03 | $12.96 | $399,000 | SEC |
| 2016 Q4 | 60,119 | 0.06 | Buy | 0.06 | $9.88 | $594,000 | SEC |